Search Page

1

Cite

Share

Death and anti-death: tumour resistance to apoptosis.

Igney FH, Krammer PH. Igney FH, et al. Among authors: krammer ph. Nat Rev Cancer. 2002 Apr;2(4):277-88. doi: 10.1038/nrc776. Nat Rev Cancer. 2002. PMID: 12001989 Review.

Cite

Share

2

Cite

Share

Manganese superoxide dismutase: a regulator of T cell activation-induced oxidative signaling and cell death.

Kamiński MM, Röth D, Sass S, Sauer SW, Krammer PH, Gülow K. Kamiński MM, et al. Among authors: krammer ph. Biochim Biophys Acta. 2012 May;1823(5):1041-52. doi: 10.1016/j.bbamcr.2012.03.003. Epub 2012 Mar 9. Biochim Biophys Acta. 2012. PMID: 22429591

Cite

Share

3

Cite

Share

Deficient activation of CD95 (APO-1/Fas)-mediated apoptosis: a potential factor of multidrug resistance in human renal cell carcinoma.

Ramp U, Dejosez M, Mahotka C, Czarnotta B, Kalinski T, Wenzel M, Lorenz I, Müller M, Krammer P, Gabbert HE, Gerharz CD. Ramp U, et al. Br J Cancer. 2000 Jun;82(11):1851-9. doi: 10.1054/bjoc.2000.1155. Br J Cancer. 2000. PMID: 10839301 Free PMC article.

Cite

Share

4

Cite

Share

Understanding apoptosis by systems biology approaches.

Lavrik IN, Eils R, Fricker N, Pforr C, Krammer PH. Lavrik IN, et al. Among authors: krammer ph. Mol Biosyst. 2009 Oct;5(10):1105-11. doi: 10.1039/b905129p. Epub 2009 Aug 3. Mol Biosyst. 2009. PMID: 19756299 Review.

Cite

Share

5

Cite

Share

Similar sensitivity of regulatory T cells towards CD95L-mediated apoptosis in patients with multiple sclerosis and healthy individuals.

Fritzsching B, Korporal M, Haas J, Krammer PH, Suri-Payer E, Wildemann B. Fritzsching B, et al. Among authors: krammer ph. J Neurol Sci. 2006 Dec 21;251(1-2):91-7. doi: 10.1016/j.jns.2006.09.006. Epub 2006 Nov 7. J Neurol Sci. 2006. PMID: 17092518

Cite

Share

6

Cite

Share

Interferon-α abrogates the suppressive effect of apoptotic cells on dendritic cells in an in vitro model of systemic lupus erythematosus pathogenesis.

Abeler-Dörner L, Rieger CC, Berger B, Weyd H, Gräf D, Pfrang S, Tarner IH, Schwarting A, Lorenz HM, Müller-Ladner U, Krammer PH, Kuhn A. Abeler-Dörner L, et al. Among authors: krammer ph. J Rheumatol. 2013 Oct;40(10):1683-96. doi: 10.3899/jrheum.121299. Epub 2013 Sep 15. J Rheumatol. 2013. PMID: 24037549

Cite

Share

7

Cite

Share

Life and Death Decisions in the CD95 System: Main Pro-and Anti-Apoptotic Modulators.

Lavrik IN, Krammer PH. Lavrik IN, et al. Among authors: krammer ph. Acta Naturae. 2009 Apr;1(1):80-3. Acta Naturae. 2009. PMID: 22649588 Free PMC article.

Cite

Share

8

Cite

Share

Targeting Thioredoxin-1 by dimethyl fumarate induces ripoptosome-mediated cell death.

Schroeder A, Warnken U, Röth D, Klika KD, Vobis D, Barnert A, Bujupi F, Oberacker T, Schnölzer M, Nicolay JP, Krammer PH, Gülow K. Schroeder A, et al. Among authors: krammer ph. Sci Rep. 2017 Feb 24;7:43168. doi: 10.1038/srep43168. Sci Rep. 2017. PMID: 28233787 Free PMC article.

Cite

Share

9

Cite

Share

The natural anticancer compound rocaglamide selectively inhibits the G1-S-phase transition in cancer cells through the ATM/ATR-mediated Chk1/2 cell cycle checkpoints.

Neumann J, Boerries M, Köhler R, Giaisi M, Krammer PH, Busch H, Li-Weber M. Neumann J, et al. Among authors: krammer ph. Int J Cancer. 2014 Apr 15;134(8):1991-2002. doi: 10.1002/ijc.28521. Epub 2013 Oct 21. Int J Cancer. 2014. PMID: 24150948

Cite

Share

10

Cite

Share

High-throughput mutation profiling of CTCL samples reveals KRAS and NRAS mutations sensitizing tumors toward inhibition of the RAS/RAF/MEK signaling cascade.

Kiessling MK, Oberholzer PA, Mondal C, Karpova MB, Zipser MC, Lin WM, Girardi M, Macconaill LE, Kehoe SM, Hatton C, French LE, Garraway LA, Polier G, Süss D, Klemke CD, Krammer PH, Gülow K, Dummer R. Kiessling MK, et al. Among authors: krammer ph. Blood. 2011 Feb 24;117(8):2433-40. doi: 10.1182/blood-2010-09-305128. Epub 2011 Jan 5. Blood. 2011. PMID: 21209378 Free PMC article.

Cite

Share